Hanson Institute Research
Lung Disease Research Unit
Chronic Inflammatory Lung Disease Research Laboratory, Pulmonary Vascular and Gene Therapy Program, Lung Transplant Research Group
Lung disease is one of the most common causes of suffering in Australia, with around 10% of the population suffering from asthma and a similar number suffering chronic obstructive pulmonary disease (COPD, often referred to as chronic bronchitis and emphysema). Lung cancer is the most common cause of cancer death, and respiratory infections are among the most common reasons for patients seeing their general practitioner. The Lung Research Unit has a comprehensive research program that has made many world recognized contributions to the understanding and treatment of the above lung diseases as well as for pulmonary hypertension and mesothelioma. Our work ranges from basic cell biology through to human clinical trials, has been published in leading journals and won recognition nationally and internationally. We are currently working on a rage of innovative treatments involving novel proteins, gene and cell therapies, and have extensive collaborations to help ensure our discoveries will make a meaningful contribution to patient care.